Pharma Bro & # 39; Martin Shkreli sues Retrophin directors from prison

Martin Shkreli, former CEO of Turing Pharmaceuticals AG, arrives at the federal court in the Brooklyn district of New York, Monday, July 31, 2017.

Peter Foley | Bloomberg | Getty Images

The Notorious Pharma Bridge & # 39; On Friday, Martin Shkreli reported two board members and the former Secretary General of his former biopharmaceutical firm Retrophin, accusing them of using fraud to eradicate him as head of the firm in 201[ads1]4.

Shkreli's lawsuit filed in federal court in Manhattan, seeking damage of more than $ 30 million.

It was filed within days after the 36-year-old Shkreli was transferred to a new prison in Pennsylvania, where he will continue to serve a seven-year sentence for fraud in connection with his two defunct hedge funds and Retrophin as he founded after the Funds financial collapse.

The aforementioned defendants in the case are Retrophin's chairman of the board, Gary Lyons, formerly the company's CEO Stephen Aselage, who is currently director, and his former chief lawyer Margaret Valeur-Jensen. 19659002] "After starting a biopharmaceutical company from scratch and turning it into a successful company worth hundreds of millions of dollars, Mr. Shkreli was uncertain and illegally excluded from the company in defense of the Defendant", the case claims.

"The defendant, who had little to do with the company's success, but was instead driven by their ego, jealousy and greed, was successful in just one thing: creating and implementing a scheme to prevent Mr. Shkreli from the company for their selfish advantage, the costume says.

"In fact, the only people benefiting from Mr. Shkrelis were cheating on the three defenders and some other people they recruited."

Shkreli's lawyer in Edward Kang's case in Philadelphia, refused to comment When contacted by CNBC

A spokesman for Retrophin refused to comment.

Valeur-Jensen did not immediately return a request for comment sent to her via her LinkedIn account.

Shkreli received national infamy in 2015 after that the company founded after receiving from Retrophin-Turing Pharmaceuticals – hiked the price of its drug Daraprim by more than 5,000%.

The drug is used to treat a parasitic infection found in pregnant women. Inside, babies and HIV patients. Turing is now known as Phoenixus AG.

In August 2017, a jury sentenced Shkreli to three of eight criminal counts associated with his hedge fund and to Retrophin. His $ 5 million release bond was recalled a month later after the trial judge counted him a danger because of his offer to his Facebook followers, with a $ 5,000 bounty for samples of Hillary Clinton's hair.

Since last year, he had served his sentence in the low-security prison in Fort Dix, NJ.

But two months ago, he was transferred to a federal prison in Brooklyn, New York, after the Wall Street Journal reported in March that he still helped "call the shots" in the Phoenixus by using a snatch pocket on Fort Dix.

This week, Shkreli was transferred to another low security prison, in Allenwood, Pennsylvania, according to the Bureau of Prison's website.

Source link

Back to top button